5Mazzola C, Lissoni F, Scarpazza P, et al. The antihypertensive effects of benazepril,a nonfulphydryl angiotensin-converting enzyme inhibitor,in patients with essential hypertension,Curr Ther Res,1989,46(4):74.
6Whalen JJ. Definition of the effective dose of the converting enzyme inhibitor benazepril. Am Heart J, 1989,117:728.
7Cuyene TT, Belier M, Sassno P, et al. Crossover design for the doze determination of angiotensin converting enzyme inhibitor hypertension. J Hypertens, 1989,7:1005.
8Giuseppe M, Daniele A,Gerard J, et al, Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronicrenal insufficiency. N Engl J Med, 1996,334:943.
9Friedrich SP, Lorell BH, Rousseau MF, et al. Intraeardiac angiotensin-converting enzyme inhibition improves diastolic function in patients with left ventricular hypertrophy due to aortic stenosis. Circulation, 1994,90(6):2761.
10Haber HL, Powers ER, Gimpile LW, et M. Intracoronary angiotensin-converting enzyme inhibition improves diastolic funtion in patlentswith hypertension left ventricular hypertrophy.Circulation, 1994 ,89(6):2616.
